{
    "nctId": "NCT02582801",
    "briefTitle": "Clinical Research of 18F-Alfatide \u2161 PET/CT in Breast Cancer",
    "officialTitle": "18F-Alfatide \u2161 PET/CT in the Diagnosis and Treatment Response Evaluation of Breast Cancer Patients",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 46,
    "primaryOutcomeMeasure": "Maximum standardized uptake value (SUVmax)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* The patients have been suspected or diagnosed with breast cancer and they have not received any treatment; It must fulfill the ethical requirements and subjects have signed an informed consent.\n\nExclusion Criteria:\n\n* Pregnancy or nursing mothers; Those patients accompanied by other serious diseases such as cardiac functional insufficiency, hepatic and renal function insufficiency.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}